Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — September 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #760

    Enig Solsen. Næsten 1/3 del af salget.

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #761

      Ja det er flot 🙂

      1 Reply Last reply
      0
      • D Offline
        D Offline
        deleted-user
        wrote on sidst redigeret af
        #762

        Hvordan er udviklingen dag til dag i salget?

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #763

          Genmab is presenting at J. P. Morgan today and at Bersteins strategic decisions CEO meeting tomorrow - maybe some words from Jan could stop us going further down

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #764

            would be nice if 2100 stands

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #765

              Cami solids trial adds a combi arm with Pembrolizumab https://clinicaltrials.gov/ct2/history/NCT03621982?A=10&B=11&C=merged#StudyPageTop
              (if that is still of interest...)

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #766

                Borsen -Stær­ke salgstal for Gen­mabs kræft­sæl­lert: Trods mod­vind fast­hol­der Citi højt kurs­mål https://borsen.dk/nyheder/virksomheder/midt-i-modvind-kommer-staerke-salgstal-for-genmab

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #767

                  We just need very very good PD-L1/4-1BB data and then Genmab could say to JNJ that they can keep Darzalex.....Genmab dont spend time on drugs thats not a 10 BBB(10 Bagger-Block-Buster) ! Eat that

                  1 Reply Last reply
                  0
                  • K Offline
                    K Offline
                    kkjoel
                    wrote on sidst redigeret af
                    #768

                    Dag-til-dag salget er steget med 3% (214,6 vs 218.2, 21 vs 22 dg).

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #769

                      lol, exactly. Dara will be only such a small % of earnings going forward, it really isn't worth our time 😉 That JPM call would be really interesting to listen to actually...

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        Plimsoller
                        wrote on sidst redigeret af
                        #770

                        Det bliver interessant at se hvad der sker med kursen når USA åbner.

                        1 Reply Last reply
                        0
                        • K Offline
                          K Offline
                          kkjoel
                          wrote on sidst redigeret af
                          #771

                          Den falder... 😉

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            Plimsoller
                            wrote on sidst redigeret af
                            #772

                            Det lyder overvejende sandsynligt 🙂 Du er lidt af en spåmand 😉

                            1 Reply Last reply
                            0
                            • G Offline
                              G Offline
                              GeorgeBest
                              wrote on sidst redigeret af
                              #773

                              Det virker som om nogle i markedet mener Genmab skal bære hele byrden af JNJs betaling til HALO. Men når jeg læser følgende sætning,så vil jeg mene det er max. en 1/5-del af HALO betalingen som Genmab skal bære: Janssen has started reducing its royalty payments to Genmab by what it claims to be Genmab’s share of Janssen’s royalty payments to Halozyme for the second quarter of 2020.

                              1 Reply Last reply
                              0
                              • G Offline
                                G Offline
                                GeorgeBest
                                wrote on sidst redigeret af
                                #774

                                Da Genmab får max 20% i royalties, så kan Genmabs andel af skaden vel ikke overstige en 1/5-del?

                                1 Reply Last reply
                                0
                                • K Offline
                                  K Offline
                                  kkjoel
                                  wrote on sidst redigeret af
                                  #775

                                  Præcis hvad jeg tænkte - det må vel være en forholdsmæssig del.. hvis der skal være NOGEN rimelighed til.

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #776

                                    Det var også dette regnestykke jeg havde i hovedet i morges da jeg skrev at det worst case kun kunne dreje sig om en mindre del af royaltyen Genmab eventuelt skal betale.

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #777

                                      Nu tjener JNJ jo ikke 100% På salget. Så vel et sted imellem dit tal og op til vel 2% vil jeg anslå.

                                      1 Reply Last reply
                                      0
                                      • K Offline
                                        K Offline
                                        kkjoel
                                        wrote on sidst redigeret af
                                        #778

                                        Nu er amerikanske retssale og rimelighed jo
                                        ikke ligefrem synonymer 😉

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          kkjoel
                                          wrote on sidst redigeret af
                                          #779

                                          But still...

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger